• 1
    Hamilton BE, Miniño AM, Martin JA, Kochanek KD, Strobino DM, Guyer B. Annual summary of vital statistics: 2005. Pediatrics 2007; 119: 345360.
  • 2
    Steer P. The epidemiology of preterm labour. BJOG 2005; 112: 13.
  • 3
    Saigal S, Stoskopf B, Streiner D, Boyle M, Pinelli J, Paneth N, Goddeeris J. Transition of extremely low-birth-weight infants from adolescence to young adulthood: comparison with normal birth-weight controls. JAMA 2006; 295: 667675.
  • 4
    Marlow N, Wolke D, Bracewell MA, Samara M, for the EPICure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. N Eng J Med 2005; 352: 919.
  • 5
    March of Dimes. United States: infant mortality overview. reg = 99&lev = 0&top = 6&slev = 1&dv = qf [Accessed 26 May 2007].
  • 6
    Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003; 101: 178193.
  • 7
    Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, Thom E, McNellis D, Copper R, Johnson F, Roberts JM, and the National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med 1996; 334: 567572.
  • 8
    Dodd JM, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth. Cochrane Database Syst Rev 2006; January 25; CD004947.
  • 9
    Keirse MJNC. Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol 1990; 97: 149154.
  • 10
    Yemini M, Borenstein R, Dreazen E, Apelman Z, Mogilner BM, Kessler I, Lancet M. Prevention of premature labor by 17α-hydroxyprogesterone caproate. Am J Obstet Gynecol 1985; 151: 574577.
  • 11
    Johnson JWC, Austin KL, Jones GS, Davis GH, King TM. Efficacy of 17α-hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med 1975; 293: 675680.
  • 12
    Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Maowad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW, Leveno KJ, Caritis SN, Iams JD, Wapner RJ, Conway D, O'Sullivan MJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, for the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 23792385.
  • 13
    da Fonseca EB, Bittar RE, Carvalho MHB, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419424.
  • 14
    Mackenzie R, Walker M, Armson A, Hannah ME. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2006; 194: 12341242.
  • 15
    American College of Obstetricians and Gynecologists. ACOG Committee opinion. Use of progesterone to reduce preterm birth. Obstet Gynecol 2003; 102: 11151116.
  • 16
    Iams JD. Supplemental progesterone to prevent preterm birth. Am J Obstet Gynecol 2003; 188: 303.
  • 17
    O'Brien JM, Adair CD, Lewis DF, Hall DR, DeFranco EA, Fusey S, et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007; 30: 687696.
  • 18
    Hoenig JM, Heisey DM. The abuse of power: the pervasive fallacy of power calculations for data analysis. Am Stat 2001; 55: 1924.
  • 19
    Lenth RV. Some practical guidelines for effective sample size determination. Am Stat 2001; 55: 187193.
  • 20
    To MS, Skentou CA, Royston P, Yu CKH, Nicolaides KH. Prediction of patient-specific risk of early preterm delivery using maternal history and sonographic measurement of cervical length: a population-based prospective study. Ultrasound Obstet Gynecol 2006; 27: 362367.
  • 21
    Grimes-Dennis J, Berghella V. Cervical length and prediction of preterm delivery. Curr Opin Obstet Gynecol 2007; 19: 191195.
  • 22
    Berghella V, Owen J, MacPherson C, Yost N, Swain M, Dildy GA III, Miodovnik M, Langer O, Sibai, for the National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU). Natural history of cervical funneling in women at high risk for spontaneous preterm birth. Obstet Gynecol 2007; 109: 863869.
  • 23
    American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Assessment of risk factors for preterm birth: clinical management guidelines for obstetrician-gynecologists. Number 31, October 2001. Obstet Gynecol 2001; 98: 709716.
  • 24
    Institute of Medicine. Preterm Birth: Causes, Consequences, and Prevention, BehrmanRE, ButlerAS (eds). National Academies Press: Washington, DC, 2007.
  • 25
    Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M. The preterm parturition syndrome. BJOG 2006; 113 (Suppl 3): 1742.
  • 26
    Rajabi MR, Dodge GR, Solomon S, Poole AR. Immunochemical and immunohistochemical evidence of estrogen-mediated collagenolysis as a mechanism of cervical dilatation in the guinea pig at parturition. Endocrinology 1991; 128: 371378.
  • 27
    Ito A, Imada K, Sato T, Kubo T, Matsushima K, Mori Y. Suppression of interleukin 8 production by progesterone in rabbit uterine cervix. Biochem J 1994; 301: 183186.
  • 28
    Chwalisz K, Quing SS, NeeF G, Elger W. The effect of antigestagen ZK 98.299 on the uterine cervix. Acta Endocrino Logica 1987; (Suppl 283): 113114, Abstract 133.
  • 29
    Fonseca E, Celik E, Parra M, Singh M, Nicolaides K, for the Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. New Engl J Med 2007; 357: 462469.
  • 30
    Landon MB, Hauth JC, Leveno KJ, Spong CY, Leindecker S, Varner MW, Moawad AH, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, Carpenter M, Peaceman AM, O'Sullivan MJ, Sibai B, Langer O, Thorp JM, Ramin SM, Mercer BM, Gabbe SG, for the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med 2004; 351: 25812589.
  • 31
    Alexander JM, Leveno KJ, Rouse DJ, Landon MB, Gilbert S, Spong CY, Varner MW, Moawad AH, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, O'Sullivan MJ, Sibai BM, Langer O, Gabbe SG, for the National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU). Comparison of maternal and infant outcomes from primary cesarean delivery during the second compared with the first stage of labor. Obstet Gynecol 2007; 109: 917921.
  • 32
    Lam F, Istwan NB, Rhea D, Smith M, Main E, Slage T, Stanziano G. Evaluation of the pregnancy prolongation index (PPI) as a measure of success of obstetric interventions in the prevention of preterm birth and associated morbidities. Am J Obstet Gynecol 2005; 192: 20472052.
  • 33
    Kleinstein J, for the Luteal Phase Study Group. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction. Fertil Steril 2005; 83: 16411649.